China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. Its products include shuangdan capsules, houerhuan anti-inflammatory capsules, shugan yipi granules, danggui tiaojing granules, huangzao granules, pingfeng shengmai capsules, danqi and naodesheng tablets. The company was founded on February 10, 2005 and is headquartered in Guangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company